Human IgE Antibody Secreting Cells in Blood, Nasal Polyps, and Bone Marrow
血液、鼻息肉和骨髓中的人类 IgE 抗体分泌细胞
基本信息
- 批准号:8779709
- 负责人:
- 金额:$ 19.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-12-04 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute-Phase ReactionAdultAffectAllergensAllergicAllergic DiseaseAmericanAntibodiesAntibody RepertoireAntibody ResponseAntigensAsthmaB-LymphocytesBasophilsBindingBiological AssayBiological Response ModifiersBloodBone MarrowCD19 geneCell modelCellsChildCollaborationsDataDerivation procedureDiscriminationDiseaseExtrinsic asthmaFDA approvedGenerationsHalf-LifeHealthHumanHuman BiologyHymenopteraHypersensitivityIgEIgG1IgG4ImmuneImmunoglobulin GImmunoglobulin-Secreting CellsIndividualInsect StingLaboratoriesLeadLifeMaintenanceMeasuresMediator of activation proteinMemoryMemory B-LymphocyteModelingMusNasal PolypsNatural HistoryPatientsPhasePlasma CellsPopulationPositioning AttributePrevalencePropertyProteomicsRegulationReporterSerumSignal TransductionSourceStructure of germinal center of lymph nodeTechnologyTestingTherapeuticTimeVaccinesVenomsasthmatic patientbasecohortcosthigh riskmast cellmouse modelnext generation sequencingnovelpathogenresponsetool
项目摘要
DESCRIPTION (provided by applicant): Allergies affect over one third of the world's population, and the prevalence of asthma is estimated at 300 million patients worldwide 17. In the US alone, asthma prevalence is 8-10% with a subset of 10% who suffer from severe disease. Allergen-specific IgE is a major mediator of severe allergic conditions and asthma exacerbations, but little is understood about the biology of human IgE in these patients. The presence of human IgE long-lived plasma cells is a matter of controversy, since mouse models show little evidence of IgE BM resident plasma cells fueling debate that IgE levels are maintained only by ongoing replenishment from short-lived ASC. In my laboratory, we have identified a new LLPC subset in the human bone marrow (BM) compartment and characterized 5 novel circulating ASC populations. In this application, we will demonstrate the presence of human IgE BM LLPC in allergic patients and understand the cellular origins of allergen-specific IgE responses during acute recall responses (after natural allergen exposures) in blood, bone marrow and nasal polyps.
描述(由申请人提供):过敏症影响世界上三分之一以上的人口,估计全世界有3亿哮喘患者17。仅在美国,哮喘患病率为8-10%,其中10%的人患有严重疾病。过敏原特异性IgE是严重过敏性疾病和哮喘恶化的主要介质,但对这些患者中人类IgE的生物学知之甚少。人IgE长寿浆细胞的存在是一个有争议的问题,因为小鼠模型显示IgE BM驻留浆细胞的证据很少,这引发了关于IgE水平仅通过短期ASC的持续补充来维持的争论。在我的实验室中,我们在人骨髓(BM)隔室中鉴定了一个新的LLPC亚群,并表征了5个新的循环ASC群体。在本申请中,我们将证明过敏患者中存在人IgE BM LLPC,并了解血液、骨髓和鼻息肉中急性回忆反应(自然过敏原暴露后)期间过敏原特异性IgE反应的细胞起源。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frances Eun-Hyung Lee其他文献
Frances Eun-Hyung Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frances Eun-Hyung Lee', 18)}}的其他基金
Human Plasma Cell Maturation & Maintenance through CD138, TNFRSF, and Modulation of Ig Secretion
人类浆细胞成熟
- 批准号:
10660723 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
使用综合生物信息学和新型体外骨髓模拟物研究人类疫苗的耐久性
- 批准号:
10453165 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
使用综合生物信息学和新型体外骨髓模拟物研究人类疫苗的耐久性
- 批准号:
10536621 - 财政年份:2019
- 资助金额:
$ 19.5万 - 项目类别:
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
使用综合生物信息学和新型体外骨髓模拟物研究人类疫苗的耐久性
- 批准号:
10320908 - 财政年份:2019
- 资助金额:
$ 19.5万 - 项目类别:
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
使用综合生物信息学和新型体外骨髓模拟物研究人类疫苗的耐久性
- 批准号:
10084803 - 财政年份:2019
- 资助金额:
$ 19.5万 - 项目类别:
Understanding Survival of Human Bone Marrow Long-Lived Plasma Cells
了解人类骨髓长寿浆细胞的存活
- 批准号:
9008805 - 财政年份:2016
- 资助金额:
$ 19.5万 - 项目类别:
Understanding Survival of Human Bone Marrow Long-Lived Plasma Cells
了解人类骨髓长寿浆细胞的存活
- 批准号:
9199574 - 财政年份:2016
- 资助金额:
$ 19.5万 - 项目类别:
Human IgE Antibody Secreting Cells in Blood, Nasal Polyps, and Bone Marrow
血液、鼻息肉和骨髓中的人类 IgE 抗体分泌细胞
- 批准号:
8630264 - 财政年份:2013
- 资助金额:
$ 19.5万 - 项目类别:
相似海外基金
Modulation of hepatic acute phase reaction and antiviral response by pro-apaptotic substances (B13)
促凋亡物质调节肝脏急性期反应和抗病毒反应(B13)
- 批准号:
57771341 - 财政年份:2008
- 资助金额:
$ 19.5万 - 项目类别:
Collaborative Research Centres
Effect of abnormal body temperature on ventilator induced lung injury and acute phase reaction
体温异常对呼吸机所致肺损伤及急性时相反应的影响
- 批准号:
18591710 - 财政年份:2006
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
gp130-dependent acute phase reaction: new therapeutical strategies to prevent vascular diseases (B 09)
gp130依赖性急性期反应:预防血管疾病的新治疗策略(B 09)
- 批准号:
5274832 - 财政年份:2001
- 资助金额:
$ 19.5万 - 项目类别:
Collaborative Research Centres
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
- 批准号:
3477337 - 财政年份:1988
- 资助金额:
$ 19.5万 - 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
- 批准号:
3477338 - 财政年份:1988
- 资助金额:
$ 19.5万 - 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
- 批准号:
3477340 - 财政年份:1988
- 资助金额:
$ 19.5万 - 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
- 批准号:
3477339 - 财政年份:1988
- 资助金额:
$ 19.5万 - 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
- 批准号:
3477341 - 财政年份:1988
- 资助金额:
$ 19.5万 - 项目类别:
CENTRAL MONOAMINES AND OPIOIDS IN ACUTE-PHASE REACTION
急性期反应中的中心单胺和阿片类药物
- 批准号:
3405544 - 财政年份:1986
- 资助金额:
$ 19.5万 - 项目类别: